Industry Trend Analysis - 13th Five-Year Plan To Reinforce Existing Trends - AUG 2017
BMI View: China's newly adopted 13th Five-Year P lan for the years 2016 to 2020 will reinforce existing trends within the healthcare sector. It includes a reform of the country's health insurance sector to mitigate inequalities in cove rage, as well as a greater emphasis on drug prices. The key new opportunit ies stem from China's relaxation of the one-child policy , which will be beneficial for companies operating in paediatrics and the women's health space .
China's 13th Five-Year Plan (2016-2020) will be a key guiding document shaping opportunities in the pharmaceutical and healthcare industry. First disclosed and adopted at the end of the Communist Party of China's National People's Congress, the five-year plan represents an expansive roadmap spanning many aspects of the economy.
Several key areas relating to the pharmaceutical industry have been identified:
Dominant Insurance Scheme Post Merger China: Universal Health Insurance Coverage By Scheme (%, 2011) Source: National Health and Family Planning Commission of China: China Statistics Yearbook of Health and Family Planning 2013, PLOS One
This article is part of our Asia coverage. To access this article subscribe now or sign up for free trial